Gavi and the Global Fund Debate
Full Debate: Read Full DebateWendy Morton
Main Page: Wendy Morton (Conservative - Aldridge-Brownhills)Department Debates - View all Wendy Morton's debates with the Foreign, Commonwealth & Development Office
(1 day, 23 hours ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
It is a pleasure to serve under your chairmanship, Ms Jardine. Let me start by congratulating the hon. Member for Milton Keynes Central (Emily Darlington) on securing this debate. I also pay tribute to my right hon. Friend the Member for Dumfriesshire, Clydesdale and Tweeddale (David Mundell), who is a powerful advocate for global health—I think we can all see why he prefers to be on this side of the dais today rather than where you are, Ms Jardine.
Global health is everybody’s health. This year we have significant replenishments for two organisations: Gavi and the Global Fund, which work on the frontline to secure our population against diseases, which do not respect borders. Gavi, the Vaccine Alliance, is a unique alliance of Governments, private sector foundations, civil society organisations and vaccine manufacturers. As we have heard, Gavi has vaccinated more than 1 billion children in 78 low-income countries and saved more than 18.8 million lives.
In 2025, Gavi is seeking its eighth replenishment for its five-year strategic period, from 2026 to 2030. It is an impressive organisation; since becoming a shadow Minister in November, I have been pleased to continue to meet Gavi regularly and participate in roundtables as it approaches this crucial milestone. The Global Fund to Fight AIDS, Tuberculosis and Malaria invests in sustainable health systems to eradicate those three diseases. It has saved an estimated 65 million lives. The Global Fund’s eighth replenishment is also happening this year, and it will cover the funding period from 2026 to 2028.
Global health is a good example of a positive impact that we can have through aid. If we look, for example, at neglected tropical diseases, we see that our science, technology and research sectors produced both of the world’s first malaria vaccines to be recommended by the World Health Organisation: Mosquirix and R21. During my time as Minister with responsibility for global health, I was fortunate enough to see the UK expertise in infectious diseases at first hand during a visit to the Liverpool School of Tropical Medicine, back in 2020. At the time, it was a Conservative Government who announced £15.5 million to support the Liverpool School of Tropical Medicine in its research on preventing the spread of infectious diseases, such as tuberculosis, and in strengthening health systems in fragile countries.
The UK is often cited as a leader in global health. In answers to several of my written questions on the topic—the Minister knows this well—Ministers start by saying:
“The UK is one of the largest donors to Gavi”.
They then give the reply that many right hon. and hon. Members will be accustomed to—that we need to wait until the spending review, and that all global health investments are being looked at in the round.
Gavi relies heavily on philanthropic foundations, notably the Gates Foundation, but there are concerns that they may have a disproportionate influence on setting the priorities for global vaccine programmes. Does the right hon. Lady agree that any reduction or pulling back of the UK’s support of those programmes could exacerbate those concerns?
The hon. Gentleman is absolutely right that Gavi has the ability to pull in many different donors, but perhaps the specific questions following the ODA cut should be directed to the Minister. Gavi is a good example of how partnership can deliver for the benefit of the most vulnerable.
Conservative Governments made significant interventions that contributed to the UK’s reputation as a global health leader. In 2015, we pledged £1.44 billion to Gavi over five years, and in 2020, when we hosted the global vaccine summit, we committed a further £1.65 billion. During the last two Global Fund replenishments, we pledged £1 billion in 2022 and £1.46 billion in 2020. Those pledges to Gavi and the Global Fund were just one part of our leadership and efforts to strengthen global health, and an incredibly important one at that.
I note from responses to my written questions that Ministers are often quite keen to highlight our record on global health, but I would like to take this opportunity to ask some questions about the Government’s record to date. Following the reduction in ODA to 0.3% of GNI, I ask the Minister: what does global health now look like from the strategic level of the Foreign, Commonwealth and Development Office? It would be helpful to know where the priorities are and whether the Government plan to continue the emphasis on multilateral NGOs such as Gavi and the Global Fund, or whether other models are to be considered.
Although the approach to global health may be changing under this Labour Government, the replenishment periods for Gavi and the Global Fund are rapidly approaching—in fact, Gavi’s is literally weeks away. I would therefore welcome some clarity from the Minister on the discussions he has had with representatives of both funds and other donor nations. I want to press him a little about the absence of any UK pledges to date. I have previously had no luck getting an answer on that through my written questions, so I will have another go today. Has he considered the impact of the UK’s apparent delay in pledging on our international reputation and our standing as a leader in global health?
Does the right hon. Lady agree that the UK’s track record on this has been quite impressive, given that other countries frankly punch below their economic weight, so this is not just about the UK’s contribution but about the role we play in ensuring other countries shoulder the burden?
The hon. Gentleman is absolutely right, and I recall that during the last replenishment, there were many conversations going on to encourage other countries and partners to step up to the plate. The UK’s leadership had a real impact at that time. In a similar vein, what is the potential impact on other countries’ pledges? Is the Minister thinking about making a reduced commitment or no pledge at all? Rather than ongoing uncertainty, it would help other donors and NGOs to know what the UK is doing, so that they can plan.
The Minister will be aware that there is a range of financial instruments available to him. One is the international finance facility for immunisation, through which £590 million of our £1.65 billion pledge in 2020 was distributed. IFFIm accelerates the delivery of vaccines by making the money from long-term Government donor pledges available immediately, allowing Gavi to vaccinate more individuals, faster. I would be grateful if the Minister updated us on any discussions he has had with Gavi and with IFFIm about its potential use to front-load any UK commitments.
I agree what a good model that is. Does the right hon. Member agree it is a model the Government could consider using for other things? An international finance facility for education has been released in the last few years. Does she agree that the Government could consider adopting this model across a range of different issues as we look to find alternative methods of development finance?
That is a really interesting point, because IFFIm has proved what can be achieved by working with other instruments. I hope that the Government will examine the options. The Minister may be able to share that information; it is not for me to say what the Government should do, but perhaps the Minister can do so in his response to the debate.
The global landscape of development is changing; we can see that across the rest of the world. For example, the US, which for so long has been an important anchor donor to a number of global health initiatives, has made dramatic reductions to USAID, so it would be helpful to know what discussions the Minister has had with his US counterparts and with other donor countries about co-ordinating our efforts, so we can maximise value for money in global health spend.
I will conclude as I started, by saying that global health is everybody’s health. I pay enormous tribute to the Global Fund and Gavi, which harness the power of donations from taxpayers in countries like the UK to end preventable deaths from treatable diseases in some of the most vulnerable parts of the world. Global health may sometimes seem like an abstract concept, but we only have to look back at recent history to see that infectious diseases do not respect borders and that global solutions are needed to keep us all safe.